SS
TIL icon

SBI Securities’s Instil Bio TIL Stock Holding History

SBI Securities’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$18 – 4221
2025
Q3 		$18 Buy
+1
New +$25 ﹤0.01% 3938

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SBI Securities's TIL Position: Q4 2025 in Review

SBI Securities sold out of Instil Bio (TIL) in Q4 2025, closing a stake of 1 share — an estimated $18 sold.

SBI Securities first reported a position in TIL in Q3 2025 and held it in 1 quarter. The position peaked at $18 in Q3 2025. 29 funds tracked by Wall St. Rank hold TIL as of Q4 2025.

  • SBI Securities reported no remaining Instil Bio position as of Q4 2025 after selling out during the quarter.
  • SBI Securities sold 1 Instil Bio share in Q4 2025, an estimated $18.
  • SBI Securities first reported a position in Instil Bio in Q3 2025 and held it in 1 quarter.
  • SBI Securities's Instil Bio position peaked at $18 in Q3 2025.
  • 29 funds tracked by Wall St. Rank held Instil Bio as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.